This new mRNA vaccine could better protect against the flu - BradfordToday.ca

The U. S.-approved vaccine — faster to produce and more precise than traditional flu shots — is awaiting the green light in Canada Reprinted with permission from Be Giant, a non-profit, non-partisan media outlet reporting on the people, places, ideas and breakthroughs shaping Canada's future. Sign up for their weekly newsletter.

The U. S.-approved vaccine — faster to produce and more precise than traditional flu shots — is awaiting the green light in Canada Reprinted with permission from Be Giant, a non-profit, non-partisan media outlet reporting on the people, places, ideas and breakthroughs shaping Canada's future. Sign up for their weekly newsletter.

The U. S.-approved vaccine — faster to produce and more precise than traditional flu shots — is awaiting the green light in Canada Reprinted with permission from Be Giant, a non-profit, non-partisan media outlet reporting on the people, places, ideas and breakthroughs shaping Canada's future. Sign up for their weekly newsletter.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.